Emerging drugs to treat OCD
Emerging drugs to treat obsessive-compulsive disorder Obsessive-compulsive disorder (OCD) is a chronic and disabling neuropsychiatric disorder with a lifetime prevalence of approximately 1 – 2% and a rate of treatment resistance of 40%. Other disorders have been...rTMS in resistant mixed states
rTMS in resistant mixed states: an exploratory study Stefano Pallanti, M.D., Ph.D. ; Giacomo Grassi, M.D. ; Sarah Antonini, M.D., Ph.D. ; Leonardo Quercioli, M.D. ; Emilia Salvadori, Ph.D and Eric Hollander, M.D. ABSTRACT Background: repetitive transcranial magnetic...TMS for the treatment of hallucinations
Transcranial Magnetic Stimulation for the Treatment of Pharmacoresistant Nondelusional Auditory Verbal Hallucinations in Dementia Anna Marras and Stefano Pallanti Abstract Auditory verbal hallucinations (AVHs) are known as a core symptom of schizophrenia, but also...Anxiety as a Core Aspect of Schizophrenia
Anxiety as a Core Aspect of Schizophrenia Stefano Pallanti & Andrea Cantisani & Giacomo Grassi Abstract The clinical relevance of anxiety disorders in schizophrenia has been neglected for a long time and has only recently become the subject of a systematic...Articolo su rTMS
Nel 2010 è stato pubblicato su Neuroscience uno studio condotto dal Prof. Stefano Pallanti in collaborazione con i medici dell’istituto sull’efficacia della Stimolazione Magnetica Transcranica ripetitiva (rTMS) nel trattamento della Depressione...
Pubblicazioni
è in uscita Firenze Neuroscienze,
click sulla copertina per scaricarlo
Publications
è in uscita Firenze Neuroscienze,
click sulla copertina per scaricarlo
Clicca per donare !
Click to donate!